![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
1. Keygesic-10
2. Magan
3. Mobidin
4. Momentum (magnesium Salicylate)
1. 18917-89-0
2. Magnesium Disalicylate
3. Magnesiumsalicylate
4. Magan
5. Magnesium Salicylate Anhydrous
6. Jq69d454n1
7. Mobidin
8. Magnesium, Bis[2-(hydroxy-.kappa.o)benzoato-.kappa.o]-, (t-4)-
9. Backache Relief
10. Chebi:6640
11. Bis(salicylato)magnesium; Magan; Magnesium Bis(salicylate); Salicylic Acid, Magnesium Salt
12. Bis(salicylato)magnesium
13. Magnesium Bis(salicylate)
14. Unii-jq69d454n1
15. Magnesium, Bis(2-(hydroxy-.kappa.o)benzoato-.kappa.o)-, (t-4)-
16. Einecs 242-669-3
17. Analate
18. Lorisal
19. Triact
20. Salicylic Acid, Magnesium Salt (2:1)
21. Magnesium;2-carboxyphenolate
22. Schembl9981
23. Chembl2106755
24. Dtxsid00889392
25. Magnesium Salicylate [mi]
26. Magnesium Salicylate (1:2)
27. Akos015901813
28. Db01397
29. Magnesium, Bis(2-hydroxybenzoato-o1,o2)-
30. Q6731407
Molecular Weight | 298.53 g/mol |
---|---|
Molecular Formula | C14H10MgO6 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 2 |
Exact Mass | 298.0327797 g/mol |
Monoisotopic Mass | 298.0327797 g/mol |
Topological Polar Surface Area | 121 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 133 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Magnesium salicylate is a common analgesic and non-steroidal anti-inflammatory drug (NSAID) used to treat mild to moderate muscular pain
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Cyclooxygenase Inhibitors
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)
Most NSAIDs act as nonselective inhibitors of the enzyme cyclooxygenase (COX), inhibiting both the cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) isoenzymes. COX catalyzes the formation of prostaglandins and thromboxane from arachidonic acid (itself derived from the cellular phospholipid bilayer by phospholipase A2). Prostaglandins act (among other things) as messenger molecules in the process of inflammation.